Why U.S. healthcare spends 18% of GDP yet misses preventable diseases—Daniel Ek reveals how Spotify's playbook applies to early detection. The Spotify founder discusses his new venture Neko Health, a $499 diagnostic scan that indexes 950 moles, screens blood markers, and tracks cardiovascular health, aiming to shift medicine from reactive to preventative. Plus his take on AI's undermarketed benefits and compute as the real regulatory frontier. Chronic disease detection achieved early is preventable and cheap, but U.S. healthcare system incentives reward acute treatment, not prevention, because insurers rarely stay with employees long enough to recoup 10-20 year payback periods.